BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34855767)

  • 1. Phenotypic characterization of carbapenem non-susceptible gram-negative bacilli isolated from clinical specimens.
    Abdeta A; Bitew A; Fentaw S; Tsige E; Assefa D; Lejisa T; Kefyalew Y; Tigabu E; Evans M
    PLoS One; 2021; 16(12):e0256556. PubMed ID: 34855767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance and detection of plasmid mediated colistin resistance mcr-1 gene among Escherichia coli and Klebsiella pneumoniae isolated from clinical samples.
    Karki D; Dhungel B; Bhandari S; Kunwar A; Joshi PR; Shrestha B; Rijal KR; Ghimire P; Banjara MR
    Gut Pathog; 2021 Jul; 13(1):45. PubMed ID: 34225805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant and carbapenemase-producing critical gram-negative bacteria isolated from the intensive care unit environment in Amhara region, Ethiopia.
    Kindu M; Moges F; Ashagrie D; Tigabu Z; Gelaw B
    PLoS One; 2023; 18(11):e0295286. PubMed ID: 38033134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of clinical isolation of carbapenem-resistant Enterobacterales and application of carbapenemase inhibitor enhancement test.
    Li H; Zhong Y; Yan Q; Liu W; Liang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1210-1216. PubMed ID: 37875361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of carbapenemase-producing Gram-negative bacilli: first report of blaNDM-1 in Enterobacter cloacae.
    Debabza M; Dziri R; Mechai A; Bouguessa A; Klibi N; Ouzari HI
    J Infect Dev Ctries; 2023 Sep; 17(9):1300-1309. PubMed ID: 37824354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia.
    Ibáñez-Prada ED; Bustos IG; Gamboa-Silva E; Josa DF; Mendez L; Fuentes YV; Serrano-Mayorga CC; Baron O; Ruiz-Cuartas A; Silva E; Judd LM; Harshegyi T; Africano HF; Urrego-Reyes J; Beltran CC; Medina S; Leal R; Stewardson AJ; Wyres KL; Hawkey J; Reyes LF
    Microbiol Spectr; 2024 Jun; 12(6):e0171423. PubMed ID: 38629835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive analysis of targeted carbapenemase genes and antibiotic susceptibility profiles among carbapenem-resistant
    Sabour S; Bantle K; Bhatnagar A; Huang JY; Biggs A; Bodnar J; Dale JL; Gleason R; Klein L; Lasure M; Lee R; Nazarian E; Schneider E; Smith L; Snippes Vagnone P; Therrien M; Tran M; Valley A; Wang C; Young EL; Lutgring JD; Brown AC
    Microbiol Spectr; 2024 Feb; 12(2):e0282823. PubMed ID: 38174931
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenotypic screening and molecular characterization of carbapenemase-producing Gram-negative bacilli recovered from febrile neutropenic pediatric cancer patients in Egypt.
    Kamel NA; El-Tayeb WN; El-Ansary MR; Mansour MT; Aboshanab KM
    PLoS One; 2018; 13(8):e0202119. PubMed ID: 30157188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of Carbapenem and Colistin Resistant Gram-Negative Bacteria Colonizing Immunocompromised SARS-CoV-2 Patients Admitted to Some Libyan Hospitals.
    Slimene K; Ali AA; Mohamed EA; El Salabi A; Suliman FS; Elbadri AA; El-Fertas FF; El-Awjly A; Shokri SA; Rolain JM; Chouchani C
    Microbiol Spectr; 2023 Jun; 11(3):e0297222. PubMed ID: 37042782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic Detection of Carbapenem-Resistant Gram-Negative Bacilli from a Clinical Specimen in Sidama, Ethiopia: A Cross-Sectional Study.
    Alemayehu T; Asnake S; Tadesse B; Azerefegn E; Mitiku E; Agegnehu A; Nigussie N; H/Mariam T; Desta M
    Infect Drug Resist; 2021; 14():369-380. PubMed ID: 33564245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude of extended-spectrum β-lactamase and carbapenemase producing Enterobacteriaceae among commonly vended street foods in Arba Minch town, southern Ethiopia.
    Alelign D; Kidanewold A
    BMC Microbiol; 2023 Dec; 23(1):393. PubMed ID: 38062376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022.
    Wise MG; Karlowsky JA; Mohamed N; Hermsen ED; Kamat S; Townsend A; Brink A; Soriano A; Paterson DL; Moore LSP; Sahm DF
    J Glob Antimicrob Resist; 2024 Jun; 37():168-175. PubMed ID: 38608936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Source-tracking ESBL-producing bacteria at the maternity ward of Mulago hospital, Uganda.
    Mayanja R; Muwonge A; Aruhomukama D; Katabazi FA; Bbuye M; Kigozi E; Nakimuli A; Sekikubo M; Najjuka CF; Kateete DP
    PLoS One; 2023; 18(6):e0286955. PubMed ID: 37289837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and clinical characteristics of patients with healthcare-acquired multidrug-resistant Gram-negative bacilli: a retrospective study from a tertiary care hospital.
    Aiesh BM; Natsheh M; Amar M; AbuTaha S; Qadi M; AbuTaha A; Sabateen A; Zyoud SH
    Sci Rep; 2024 Feb; 14(1):3022. PubMed ID: 38321071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance.
    Ikenoue C; Matsui M; Inamine Y; Yoneoka D; Sugai M; Suzuki S;
    BMC Infect Dis; 2024 Feb; 24(1):209. PubMed ID: 38360618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of OXA-48 Gene in Carbapenem-Resistant
    Gurung S; Kafle S; Dhungel B; Adhikari N; Thapa Shrestha U; Adhikari B; Banjara MR; Rijal KR; Ghimire P
    Infect Drug Resist; 2020; 13():2311-2321. PubMed ID: 32765007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia.
    Tekele SG; Teklu DS; Tullu KD; Birru SK; Legese MH
    PLoS One; 2020; 15(11):e0241984. PubMed ID: 33180785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
    Maina JW; Mutua JM; Musyoki AM
    BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.
    Karaiskos I; Giamarellou H
    Expert Opin Pharmacother; 2014 Jul; 15(10):1351-70. PubMed ID: 24766095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with non-carbapenemase mediated carbapenem resistance of Gram-negative bacteria: a retrospective case-control study.
    Müller M; Wiencierz A; Gehringer C; Muigg V; Bassetti S; Siegemund M; Hinic V; Tschudin-Sutter S; Egli A
    Int Microbiol; 2024 Apr; 27(2):597-606. PubMed ID: 37556067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.